<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b"><labelDrug name="Kayexalate"><Normalization><mmtx cui="C0124498" preferredWord="Kayexalate" semType="phsu, orch"/></Normalization></labelDrug><generic name="sodium polystyrene sulfonate"/><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1" text="Drug Label for drug brand Kayexalate, containing sodium polystyrene sulfonate." type="negative"><entity charOffset="0:19" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Kayexalate," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="49:77" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.1" text="sodium polystyrene sulfonate" type="Biomedical_Entity"><Normalization><mmtx cui="C0142915" phraseText="sodium polystyrene sulfonate." preferredWord="Sodium polystyrene sulfonate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="26:36" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.2" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="Drug Label for drug brand Kayexalate," preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.1"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.2"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.1.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" lineNumber="15" text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. " type="irregular"><entity charOffset="9:28" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.1" text="intestinal necrosis" type="Specific_Interaction"/><entity charOffset="60:99" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.3" text="serious gastrointestinal adverse events" type="Specific_Interaction"/><entity charOffset="101:109" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.5" text="bleeding" type="Specific_Interaction"/><entity charOffset="129:140" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.7" text="perforation" type="Specific_Interaction"/><entity charOffset="9:28" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.8" text="intestinal necrosis" type="SPAN"/><entity charOffset="60:99" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.9" text="serious gastrointestinal adverse events" type="SPAN"/><entity charOffset="101:109" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.10" text="bleeding" type="SPAN"/><entity charOffset="111:127" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.11" text="ischemic colitis" type="SPAN"><Normalization><mmtx cui="C0162529" phraseText="ischemic colitis," preferredWord="Colitis, Ischemic" semType="dsyn"/></Normalization></entity><entity charOffset="129:140" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.12" text="perforation" type="SPAN"/><entity charOffset="181:191" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.13" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="with KAYEXALATE use." preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.1"><relations><relation type="hasObject"><labelDrug text="Kayexalate"/><normalization><mmtx><preferredWord>Kayexalate</preferredWord><phraseText>with KAYEXALATE use.</phraseText><cuiCode>C0124498</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.ddi.2"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.3"><relations><relation type="hasObject"><labelDrug text="Kayexalate"/><normalization><mmtx><preferredWord>Kayexalate</preferredWord><phraseText>with KAYEXALATE use.</phraseText><cuiCode>C0124498</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.ddi.3"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.5"><relations><relation type="hasObject"><labelDrug text="Kayexalate"/><normalization><mmtx><preferredWord>Kayexalate</preferredWord><phraseText>with KAYEXALATE use.</phraseText><cuiCode>C0124498</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.ddi.4"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.7"><relations><relation type="hasObject"><labelDrug text="Kayexalate"/><normalization><mmtx><preferredWord>Kayexalate</preferredWord><phraseText>with KAYEXALATE use.</phraseText><cuiCode>C0124498</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7" lineNumber="15" text="The majority of these cases reported the concomitant use of sorbitol. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="9:28" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.1" text="intestinal necrosis" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="9:28" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.8" text="intestinal necrosis" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="60:99" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.3" text="serious gastrointestinal adverse events" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="60:99" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.9" text="serious gastrointestinal adverse events" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="101:109" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.5" text="bleeding" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="101:109" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.10" text="bleeding" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="111:127" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.11" text="ischemic colitis" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="129:140" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.7" text="perforation" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" Text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "/><anaphoraEntity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.1" text="cases" type="Expression"/><antecedentEntity charOffset="129:140" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.12" text="perforation" type="SPAN"/></anaphoraRelation><entity charOffset="22:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.7" text="cases" type="Specific_Interaction"/><entity charOffset="60:68" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.8" text="sorbitol" type="Drug"><Normalization><mmtx cui="C0037688" phraseText="the concomitant use of sorbitol." preferredWord="Sorbitol" semType="phsu, carb"/><RxNorm RxCui="9945"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.8"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.13"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7.e.8"/></sentence><sentence biomedicalEntities="1" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9" lineNumber="15" text="Concomitant administration of sorbitol is not recommended (see PRECAUTIONS, Drug Interactions)." type="irregular"><entity charOffset="42:57" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.e.1" text="not recommended" type="Caution_Interaction"/><entity charOffset="30:38" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.e.2" text="sorbitol" type="Drug"><Normalization><mmtx cui="C0037688" phraseText="Concomitant administration of sorbitol" preferredWord="Sorbitol" semType="phsu, carb"/><RxNorm RxCui="9945"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6" text="Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with KAYEXALATE use. "><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.6.e.13"/></ellipsisSentence><middleSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.7" text="The majority of these cases reported the concomitant use of sorbitol. "/><middleSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.8" text="Risk factors for gastrointestinal adverse events were present in many of the cases including prematurity, history of intestinal disease or surgery, hypovolemia, and renal insufficiency and failure. "/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.9.e.2"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.15" text="Since effective lowering of serum potassium with KAYEXALATE may take hours to days, treatment with this drug alone may be insufficient to rapidly correct severe hyperkalemia associated with states of rapid tissue breakdown (e.g., burns and renal failure) or hyperkalemia so marked as to constitute a medical emergency. " type="negative"><entity charOffset="34:43" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.15.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="effective lowering of serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="49:59" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.15.e.1" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="with KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.15.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.15.e.1"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.20" text="Since intracellular potassium deficiency is not always reflected by serum potassium levels, the level at which treatment with KAYEXALATE should be discontinued must be determined individually for each patient. " type="negative"><entity charOffset="126:136" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.20.e.0" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="with KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="74:83" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.20.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="reflected by serum potassium levels," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.20.e.1" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.20.e.0"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28" text="Like all cation-exchange resins, KAYEXALATE is not totally selective (for potassium) in its actions, and small amounts of other cations such as magnesium and calcium can also be lost during treatment. " type="negative"><entity charOffset="158:165" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="74:83" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="for potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="33:43" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.2" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.1" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.0"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.0"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.28.e.1"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.29" text="Accordingly, patients receiving KAYEXALATE should be monitored for all applicable electrolyte disturbances." type="negative"><entity charOffset="82:93" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.29.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="monitored for all applicable electrolyte disturbances." preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="32:42" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.29.e.1" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.29.e.1" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.29.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31" lineNumber="42" text="Systemic alkalosis has been reported after cation-exchange resins were administered orally in combination with nonabsorbable cation-donating antacids and laxatives such as magnesium hydroxide and aluminum carbonate. " type="regular"><entity charOffset="111:140|154:163" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.1" text="nonabsorbable cation-donating laxatives" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="172:191" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.2" text="magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="laxatives such as magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="111:149" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.4" text="nonabsorbable cation-donating antacids" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="196:214" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.5" text="aluminum carbonate" type="Drug"><Normalization><mmtx cui="C0301464" phraseText="aluminum carbonate." preferredWord="Aluminum carbonate" semType="phsu, orch"/><RxNorm RxCui="1311504"/></Normalization></entity><entity charOffset="9:18" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.7" text="alkalosis" type="Specific_Interaction"><Normalization><mmtx cui="C0002063" phraseText="Systemic alkalosis" preferredWord="Alkalosis" semType="dsyn"/></Normalization></entity><entity charOffset="43:65" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.8" text="cation-exchange resins" type="Drug_Class"><Normalization><RxNorm RxCui="2161"/></Normalization></entity><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.2" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.1"/><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.5" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.4"/><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.7"><relations><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.8" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.4" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.7" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.8" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.1" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.7" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.1" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.31.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32" lineNumber="42" text="Magnesium hydroxide should not be administered with KAYEXALATE. " type="regular"><entity charOffset="27:46" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.1" text="not be administered" type="Caution_Interaction"/><entity charOffset="52:62" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.2" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="administered with KAYEXALATE." preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.3" text="Magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="Magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.1"><relations><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.2" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.32.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33" lineNumber="42" text="One case of grand mal seizure has been reported in a patient with chronic hypocalcemia of renal failure who was given KAYEXALATE with magnesium hydroxide as laxative. " type="regular"><entity charOffset="157:165" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.1" text="laxative" type="Drug_Class"><Normalization><mmtx cui="C0282090" phraseText="as laxative." preferredWord="Laxatives" semType="phsu"/><RxNorm RxCui="81973"/></Normalization></entity><entity charOffset="134:153" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.2" text="magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="KAYEXALATE with magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="12:29" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.4" text="grand mal seizure" type="Specific_Interaction"><Normalization><mmtx cui="C0494475" phraseText="One case of grand mal seizure" preferredWord="Tonic - clonic seizures" semType="dsyn"/></Normalization></entity><entity charOffset="66:103" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.5" text="chronic hypocalcemia of renal failure" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="of renal failure" preferredWord="Kidney Failure" semType="dsyn"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.6" text="One case" type="SPAN"/><entity charOffset="118:128" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.7" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE with magnesium hydroxide" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.2" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.1"/><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.4"><relations><relation type="hasContext"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.5" ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.7" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.2" evidence="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.6" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.33.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.36" text="Caution is advised when KAYEXALATE is administered to patients who cannot tolerate even a small increase in sodium loads (i.e., severe congestive heart failure, severe hypertension, or marked edema). " type="negative"><entity charOffset="24:34" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.36.e.0" text="kayexalate" type="Biomedical_Entity"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="108:114" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.36.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="a small increase in sodium loads" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.36.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.36.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41" lineNumber="53" text="The simultaneous oral administration of KAYEXALATE with nonabsorbable cation-donating antacids and laxatives may reduce the resin's potassium exchange capability." type="regular"><anaphoraRelation><anaphoraEntity charOffset="124:129" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.4" text="resin" type="Expression"/><antecedentEntity charOffset="17-50" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.6" text="oral administration of KAYEXALATE" type="Drug"/></anaphoraRelation><entity charOffset="113:119|132:161" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.1" text="reduce potassium exchange capability" type="Specific_Interaction"/><entity charOffset="56:85|99:108" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.2" text="nonabsorbable cation-donating laxatives" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><mmtx cui="C0282090" phraseText="laxatives" preferredWord="Laxatives" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="56:94" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.3" text="nonabsorbable cation-donating antacids" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="17:50" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.6" text="oral administration of KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="The simultaneous oral administration of KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.4" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.4" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.41.e.2"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.42" text="Non-absorbable cation-donating antacids and laxatives" type="negative"><entity charOffset="31:39" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.42.e.0" text="antacids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003138" phraseText="Non-absorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="863"/></Normalization></entity><entity charOffset="44:53" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.42.e.1" text="laxatives" type="Biomedical_Entity"><Normalization><mmtx cui="C0282090" phraseText="laxatives" preferredWord="Laxatives" semType="phsu"/><RxNorm RxCui="81973"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.42.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.42.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43" lineNumber="55" text="Systemic alkalosis has been reported after cation-exchange resins were administered orally in combination with nonabsorbable cation-donating antacids and laxatives such as magnesium hydroxide and aluminum carbonate. " type="regular"><entity charOffset="111:140|154:163" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.1" text="nonabsorbable cation-donating laxatives" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="172:191" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.2" text="magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="laxatives such as magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="111:149" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.4" text="nonabsorbable cation-donating antacids" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="with nonabsorbable cation-donating antacids" preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="196:214" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.5" text="aluminum carbonate" type="Drug"><Normalization><mmtx cui="C0301464" phraseText="aluminum carbonate." preferredWord="Aluminum carbonate" semType="phsu, orch"/><RxNorm RxCui="1311504"/></Normalization></entity><entity charOffset="9:18" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.7" text="alkalosis" type="Specific_Interaction"><Normalization><mmtx cui="C0002063" phraseText="Systemic alkalosis" preferredWord="Alkalosis" semType="dsyn"/></Normalization></entity><entity charOffset="43:65" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.8" text="cation-exchange resins" type="Drug_Class"><Normalization><RxNorm RxCui="2161"/></Normalization></entity><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.2" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.1"/><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.5" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.4"/><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.8" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.1" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.7" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.8" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.4" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.7" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.4" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.43.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44" lineNumber="55" text="Magnesium hydroxide should not be administered with KAYEXALATE. " type="regular"><entity charOffset="27:46" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.1" text="not be administered" type="Caution_Interaction"/><entity charOffset="52:62" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.2" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="administered with KAYEXALATE." preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.3" text="Magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="Magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.2" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.44.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45" lineNumber="55" text="One case of grand mal seizure has been reported in a patient with chronic hypocalcemia of renal failure who was given KAYEXALATE with magnesium hydroxide as a laxative." type="regular"><entity charOffset="159:167" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.1" text="laxative" type="Drug_Class"><Normalization><mmtx cui="C0282090" phraseText="as a laxative." preferredWord="Laxatives" semType="phsu"/><RxNorm RxCui="81973"/></Normalization></entity><entity charOffset="134:153" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.2" text="magnesium hydroxide" type="Drug"><Normalization><mmtx cui="C0024476" phraseText="KAYEXALATE with magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="12:29" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.4" text="grand mal seizure" type="Specific_Interaction"><Normalization><mmtx cui="C0494475" phraseText="One case of grand mal seizure" preferredWord="Tonic - clonic seizures" semType="dsyn"/></Normalization></entity><entity charOffset="66:103" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.5" text="chronic hypocalcemia of renal failure" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="of renal failure" preferredWord="Kidney Failure" semType="dsyn"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.6" text="One case" type="SPAN"/><entity charOffset="118:128" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.7" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE with magnesium hydroxide" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><drugClassMembership drug="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.2" drugClass="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.1"/><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.4"><relations><relation type="hasContext"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.5"/></relation><relation type="hasEvidence"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.5" ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.7" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.2" evidence="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.6" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.45.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46" lineNumber="56" text="Intestinal obstruction due to concretions of aluminum hydroxide when used in combination with KAYEXALATE has been reported." type="regular"><entity charOffset="0:22" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.1" text="Intestinal obstruction" type="Specific_Interaction"><Normalization><mmtx cui="C0021843" phraseText="Intestinal obstruction due to concretions of aluminum hydroxide" preferredWord="Intestinal Obstruction" semType="dsyn"/><mmtx cui="C0014364" phraseText="Intestinal obstruction due to concretions of aluminum hydroxide" preferredWord="Concretion of intestine" semType="dsyn"/></Normalization></entity><entity charOffset="94:104" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.2" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="with KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="45:63" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.3" text="aluminum hydroxide" type="Drug"><Normalization><mmtx cui="C0002371" phraseText="Intestinal obstruction due to concretions of aluminum hydroxide" preferredWord="Aluminum Hydroxide" semType="inch, phsu"/><mmtx cui="C0002371" phraseText="Intestinal obstruction due to concretions of aluminum hydroxide" preferredWord="Aluminum Hydroxide" semType="inch, phsu"/><RxNorm RxCui="1311504"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.2" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.46.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.48" text="The toxic effects of digitalis on the heart, especially various ventricular arrhythmias and A-V nodal dissociation, are likely to be exaggerated by hypokalemia, even in the face of serum digoxin concentrations in the &quot;normal range&quot;. " type="negative"><entity charOffset="21:30" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.48.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="The toxic effects of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="187:194" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.48.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="even in the face of serum digoxin concentrations" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.48.e.0" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.48.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51" lineNumber="60" text="Concomitant use of Sorbitol with KAYEXALATE has been implicated in cases of intestinal necrosis, which may be fatal. " type="regular"><entity charOffset="76:95" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.1" text="intestinal necrosis" type="Specific_Interaction"/><entity charOffset="19:27" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.2" text="Sorbitol" type="Drug"><Normalization><mmtx cui="C0037688" phraseText="Concomitant use of Sorbitol" preferredWord="Sorbitol" semType="phsu, carb"/><RxNorm RxCui="9945"/></Normalization></entity><entity charOffset="33:43" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.3" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="with KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.1"><relations><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.3" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.52" lineNumber="60" text="Therefore, concomitant administration is not recommended. " type="irregular"><entity charOffset="41:56" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.52.e.1" text="not recommended" type="Caution_Interaction"/><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.52.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.52.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51" text="Concomitant use of Sorbitol with KAYEXALATE has been implicated in cases of intestinal necrosis, which may be fatal. "><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51" text="Concomitant use of Sorbitol with KAYEXALATE has been implicated in cases of intestinal necrosis, which may be fatal. "><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.51.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55" lineNumber="62" text="KAYEXALATE may decrease absorption of lithium." type="regular"><entity charOffset="15:34" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.1" text="decrease absorption" type="Decrease_Interaction"/><entity charOffset="38:45" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="absorption of lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.3" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.1"><relations><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.3" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.2" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.55.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57" lineNumber="64" text="KAYEXALATE may decrease absorption of thyroxine." type="regular"><entity charOffset="15:34" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.1" text="decrease absorption" type="Decrease_Interaction"/><entity charOffset="0:10" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.2" text="KAYEXALATE" type="Drug"><Normalization><mmtx cui="C0124498" phraseText="KAYEXALATE" preferredWord="Kayexalate" semType="phsu, orch"/><RxNorm RxCui="51670"/></Normalization></entity><entity charOffset="38:47" id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.3" text="thyroxine" type="Drug"><Normalization><mmtx cui="C0040165" phraseText="absorption of thyroxine." preferredWord="Thyroxine" semType="phsu, aapp, horm"/><RxNorm RxCui="10582"/></Normalization></entity><drugInteraction id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.ddi.1"><interaction trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.2" e2="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.3" trigger="Dailymed.60f6da2c-35d0-47bb-b4eb-40ef8d8cff1b.s.57.e.1" type="Decrease_Interaction"/></sentence><positiveExamples number="16"/><negativeExamples number="15"/></document>